Lindbrook Capital, LLC - MYOVANT SCIENCES LTD ownership

MYOVANT SCIENCES LTD's ticker is MYOV and the CUSIP is G637AM102. A total of 108 filers reported holding MYOVANT SCIENCES LTD in Q1 2021. The put-call ratio across all filers is 5.85 and the average weighting 0.1%.

Quarter-by-quarter ownership
Lindbrook Capital, LLC ownership history of MYOVANT SCIENCES LTD
ValueSharesWeighting
Q4 2022$2,426
+21.3%
900.0%0.00%
Q3 2022$2,000
+100.0%
900.0%0.00%
Q2 2022$1,000
-50.0%
90
-35.7%
0.00%
Q1 2022$2,000
+100.0%
140
+55.6%
0.00%
Q4 2021$1,000
-95.7%
90
-91.0%
0.00%
-100.0%
Q2 2021$23,000
+9.5%
1,0000.0%0.01%0.0%
Q1 2021$21,000
-25.0%
1,0000.0%0.01%
-28.6%
Q4 2020$28,000
-60.0%
1,000
-80.0%
0.01%
-63.2%
Q3 2020$70,000
+600.0%
5,000
+900.0%
0.02%
+533.3%
Q2 2020$10,0005000.00%
Other shareholders
MYOVANT SCIENCES LTD shareholders Q1 2021
NameSharesValueWeighting ↓
ACT CAPITAL MANAGEMENT, LLC 65,000$808,0001.13%
Bellevue Group AG 5,919,639$73,581,0001.04%
Rhenman & Partners Asset Management AB 310,000$3,853,0000.44%
Hennion & Walsh Asset Management, Inc. 279,335$3,472,0000.22%
TORRAY INVESTMENT PARTNERS LLC 81,621$1,015,0000.19%
PLATINUM INVESTMENT MANAGEMENT LTD 302,120$3,755,0000.14%
Virtus ETF Advisers LLC 22,356$278,0000.10%
Tarbox Family Office, Inc. 27,500$342,0000.08%
BOURGEON CAPITAL MANAGEMENT LLC 15,200$189,0000.05%
JANUS HENDERSON GROUP PLC 5,449,107$67,735,0000.05%
View complete list of MYOVANT SCIENCES LTD shareholders